Oncology News

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in people with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). The study m...

LONDON--(BUSINESS WIRE)--A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection of Oesophageal and stomach cancers, some of the hardest cancers to diagnose early and among those with the poorest outcomes in England. Delivered in partnership between AstraZeneca, C the Signs, NHS Suffolk and North East Essex Integrated Care Board, Health Innovation East and GP Primary Choice, the programme represents the first time in England t...

SOPHIA-ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI)-powered Software as a Medical Device (SaMD) solutions for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced it has achieved the globally recognized ISO 13485:2016 certification for its Quality Manage...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Radio One and Reach Media, the audio divisions of Urban One, partnered with St. Jude Children’s Research Hospital® for the annual Urban Cares for St. Jude Kids® broadcast held March 12 and 13. The event raised $1.7 million to support research and treatment by St. Jude of life-threatening childhood diseases. “For nearly twenty years, Urban One has rallied listeners across the nation on behalf of St. Jude families,” said Ike Anand, President and CEO of ALSAC, the...

BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4, its next-generation platform. Built on Ibex’s clinically validated algorithms1-10 and developed in close collaboration with the world’s leading pathology labs, Ibex 4 is designed to transform the diagnostic journey, delivering unprecedented value to pathologists, laboratories, and patients. As pathology departments worldwide face rising case vol...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Crossbow announced it raised $77 million in a Series B financing that will advance the development of TCR-mimetic antibody therapies to treat cancer....

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three and 12 months ended December 31, 2025 after market close on Wednesday, March 25, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Tim...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 28 abstracts, including 3 oral sessions, showcasing advances in methylation-based tumor classification and liquid biopsy technology at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California taking place April 17 - 22, 2026. Key data that will be presented include: An oral present...

CLINTON, Mo.--(BUSINESS WIRE)--Golden Valley Memorial Healthcare (GVMH) is proud to announce the launch of its new Mobile Mammo RV, a fully equipped, state-of-the-art mobile mammography unit offering advanced 3D mammograms, the highest level of breast imaging technology available, designed to bring high-quality breast cancer screenings directly to women throughout the region. Breast cancer is one of the most frequently diagnosed cancers among women in Missouri. Early detection remains the key t...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma announced upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting April 17-22 in San Diego....